Conformis, Inc. to Present at the Canaccord Genuity Musculoskeletal Conference
12 mai 2021 18h10 HE
|
Conformis, Inc.
BILLERICA, Mass., May 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. Announces 510(k) Clearance for Identity Imprint™ Knee Replacement System
10 mai 2021 07h30 HE
|
Conformis, Inc.
BILLERICA, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration for the Company’s Identity Imprint Knee...
Conformis Reports First Quarter 2021 Financial Results
05 mai 2021 16h05 HE
|
Conformis, Inc.
BILLERICA, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis Announces Achievement of Third Milestone Under Development and License Agreements
22 avr. 2021 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it received 510(k) clearance by the U.S. Food and Drug Administration for patient-specific...
Conformis Announces License Agreement with Paragon 28
19 avr. 2021 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a license agreement with Paragon 28, Inc., granting Paragon 28 a...
Global Orthopedic Devices Market 2021-2025 - Priority of Elective Surgeries in Post-COVID-19 World to Spur Demand
15 avr. 2021 06h53 HE
|
Research and Markets
Dublin, April 15, 2021 (GLOBE NEWSWIRE) -- The "Orthopedic Devices Market - Global Industry Analysis (2017 - 2020), Growth Trends and Market Forecast (2021 - 2025)" report has been added to...
Conformis, Inc. to Release First Quarter 2021 Financial Results on May 5, 2021
07 avr. 2021 07h30 HE
|
Conformis, Inc.
BILLERICA, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the first quarter ended March 31, 2021 after the...
Conformis, Inc. Announces Clearance in Australia for iTotal® PS, the Only Personalized, Posterior-Stabilized Total Knee Replacement System
01 mars 2021 17h45 HE
|
Conformis, Inc.
BILLERICA, Mass., March 01, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) today announced the clearance of its patient-specific iTotal® PS total knee replacement system by the Therapeutic...
Conformis, Inc. to Participate in Upcoming Investor Conferences
25 févr. 2021 08h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. Announces Pricing of $85 Million Underwritten Offering of Common Stock
12 févr. 2021 08h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has priced an underwritten public offering of 80,952,381 shares of its common stock at an...